Cronograma de promoção Kura Oncology, Inc.
Agenda avançada
Gráfico simples
Sobre a empresa
Kura Oncology, Inc., биофармацевтическая компания клинической стадии, разрабатывает лекарства для лечения рака в Соединенных Штатах. Его портфель состоит из кандидатов на низкомолекулярные продукты, которые нацелены на рак.
Mais detalhesP/BV | 2.6 |
---|---|
EV/EBITDA | -8.17 |
EBITDA | -0.0675 |
Цена ао | 20.71 |
Сайт | https://kuraoncology.com |
Див.доход ао | 0 |
ISIN | US50127T1097 |
Число акций ао | 0.07323 млрд |
Валюта | usd |
IPO date | 2015-09-22 |
Sector | Health Care |
Industry | Biotechnology |
Валюта отчета | usd |
Alteração de preço por dia: | 0% (18.58) |
---|---|
Alteração de preço por semana: | +3.86% (17.89) |
Alteração de preço por mês: | -11.02% (20.88) |
Alteração de preço em 3 meses: | -20.02% (23.23) |
Mudança de preço em seis meses: | +3.28% (17.99) |
Mudança de preço por ano: | +115.8% (8.61) |
Mudança de preço em 3 anos: | +5.81% (17.56) |
Mudança de preço em 5 anos: | +26.48% (14.69) |
Mudança de preço desde o início do ano: | +97.87% (9.39) |
|
Subestimação
|
Eficiência
|
|||||||||||||||||||||||||||||||||||||
Dividendos
|
Obrigação
|
Impulso de crescimento
|
Instituições | Volume | Compartilhar, % |
---|---|---|
Suvretta Capital Management, LLC | 7 | 9.28 |
Blackrock Inc. | 7 | 9.06 |
EcoR1 Capital, LLC | 6 | 7.62 |
Deerfield Management Company, L.P. (Series C) | 5 | 7.1 |
BVF Inc. | 5 | 6.28 |
State Street Corporation | 4 | 5.51 |
Vanguard Group Inc | 4 | 5.34 |
Avoro Capital Advisors LLC | 4 | 5.05 |
Paradigm Biocapital Advisors LP | 3 | 4.12 |
Holocene Advisors, LP | 2 | 3.2 |
ETF | Compartilhar, % | Rentabilidade para o ano, % | Dividendos, % |
---|---|---|---|
Avantis U.S Small Cap Equity ETF | 0.02451 | 35.517080018718 | 1.68271 |
Avantis Responsible U.S. Equity ETF | 0.00729 | 34.234643935068 | 1.45257 |
Avantis U.S. Equity ETF | 0.00459 | 37.016870113839 | 1.59151 |
Virtus LifeSci Biotech Clinical Trials ETF | 0.76958 | 77.329244365683 | 0.33 |
JPMorgan BetaBuilders U.S. Small Cap Equity Fund | 0.07301 | 37.61291904149 | 1.59225 |
ProShares Ultra Nasdaq Biotechnology | 0.10254 | 58.954326923077 | 0.85651 |
Range Cancer Therapeutics ETF | 1.26015 | 58.680203045685 | 0.11955 |
Dimensional U.S. Core Equity 2 ETF | 0.00869 | 37.528779739064 | 1.47098 |
Dimensional US Core Equity Market ETF | 0.00309 | 35.65815324165 | 1.40618 |
Dimensional U.S. Equity ETF | 0.00173 | 36.134982184029 | 1.3557 |
Invesco Dorsey Wright SmallCap Momentum ETF | 0.34292 | 42.452031602709 | 0.61241 |
iShares ESG Aware MSCI USA Small-Cap ETF | 0.05021 | 39.294631710362 | 1.49366 |
Fidelity MSCI Health Care Index ETF | 0.0144 | 21.181088923024 | 1.46057 |
Fidelity Small-Mid Multifactor ETF | 0.11582 | 39.592616168046 | 1.59943 |
Goldman Sachs ActiveBeta US Small Cap Equity ETF | 0.03223 | 41.265441455097 | 1.41955 |
ProShares Hedge Replication ETF | 0.00895 | 6.8665973306333 | 1.47892 |
Humankind US Stock ETF | 0.00743 | 22.971795629061 | 1.99919 |
Invesco Nasdaq Biotechnology ETF | 0.15468 | 29.399255715045 | 0.8565 |
iShares Morningstar Small-Cap ETF | 0.02369 | 37.681332167863 | 1.60498 |
iShares Morningstar Small Cap Value ETF | 0.04876 | 40.493824576094 | 2.50476 |
iShares Russell 2000 Growth ETF | 0.11243 | 47.42032299557 | 0.6026 |
iShares Russell 3000 ETF | 0.00236 | 37.942616648456 | 1.43482 |
iShares Morningstar Small-Cap ETF | 0.02369 | 410.50632631881 | 1.60498 |
iShares Morningstar Small-Cap Value ETF | 0.04876 | 252.86210418795 | 2.50476 |
Direxion Daily S&P Biotech Bull 3x Shares | 0.21268 | 5201.8382352941 | 0.25924 |
Nuveen ESG Small-Cap ETF | 0.08804 | 36.100211288862 | 1.41019 |
Invesco FTSE RAFI US 1500 Small-Mid ETF | 0.01698 | 39.993646759848 | 1.75869 |
Schwab U.S. Small-Cap ETF | 0.04247 | -30.367553865653 | 1.51433 |
Schwab U.S. Broad Market ETF | 0.00314 | -53.970149253731 | 1.43354 |
FlexShares Morningstar US Market Factor Tilt Index Fund | 0.00952 | 37.307074947524 | 1.69572 |
ProShares UltraPro Russell2000 | 0.03282 | 125.96465921385 | 1.47873 |
Vanguard U.S. Momentum Factor ETF | 0.08 | 52.778724259342 | 1.05834 |
Vanguard Russell 3000 ETF | 0 | 38.467141890837 | 1.43817 |
Vanguard Russell 2000 Growth ETF | 0.11 | 46.764050831914 | 0.60264 |
Vanguard Russell 2000 ETF | 0.06 | 41.410408042578 | 1.48801 |
Principal Healthcare Innovators ETF | 0.15482 | 631.79771324797 | 0.8416 |
Future Tech ETF | 0.15482 | 412.888593871 | 0.8416 |
Supervisor | Cargo | Pagamento | Ano de nascimento |
---|---|---|---|
Dr. Troy Edward Wilson J.D., Ph.D. | Chairman, CEO & President | 1.06M | 1969 (55 anos) |
Ms. Kathleen Ford | Chief Operating Officer | 754.24k | 1947 (77 anos) |
Dr. Stephen Dale M.D. | Chief Medical Officer | 684.41k | 1972 (52 ano) |
Mr. Thomas Doyle | Senior Vice President of Finance & Accounting | N/A | 1971 (53 ano) |
Mr. Pete De Spain | Executive Vice President of Investor Relations & Corporate Communications | N/A | |
Ms. Teresa Brophy Bair Esq., J.D. | Chief Legal Officer & Corporate Secretary | N/A | 1971 (53 ano) |
Dr. Roger Bakale Ph.D. | Senior Vice President of Manufacturing & Supply Chain | N/A | |
Ms. Maureen Clancy M.B.A. | VP and Global Head of Program Leadership & Project Management | N/A | |
Dr. Mollie Leoni M.D. | Executive Vice President of Clinical Development | N/A | |
Mr. Brian T. Powl M.B.A., M.S. | Chief Commercial Officer | N/A | 1974 (50 anos) |
Endereço: United States, San Diego. CA, 12730 High Bluff Drive - abrir no Google Maps, abrir mapas Yandex
Site: https://kuraoncology.com
Site: https://kuraoncology.com